Cohen's SAC Capital Discloses 8.6% Stake In Rocket-Stock Vanda (VNDA)
Up)
In a 13G filing on Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA), Steven Cohen's SAC Capital hedge fund disclosed an 8.6% stake, or 2,279,423 shares, in the company. A 13G indiates a 'passive investment' over 5%.
Shares of have surged over 10x since announcing FDA approval for its schizophrenia drug in early-May.
Shares of have surged over 10x since announcing FDA approval for its schizophrenia drug in early-May.
You May Also Be Interested In
Create E-mail Alert Related Categories
13Gs, Momentum MoversRelated Entities
SAC Capital, Steven A. Cohen, Hedge Funds, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
